sponsored by
BioTech Session

Innovation and Technology

Healthcare and technology go side by side as the future aproches a more persolised medicine and for this reason we introduce you the BioTech Session.
Be prepared to hear about the latest achievements in technology and how impactful it can be on healthcare.

Sara Abalde-Cela, PhD
CTO and co-founder of RUBYnanomed
Researcher within the Medical Devices Group, on the Iberian Nanotechnology Laboratory

Professor Sara Abalde-Cela is a researcher on the Iberian Nanotechnology Laboratory, in Braga. In 2018 she co-founded RUBYnanomed, a startup focused on bringing circulating tumour cells technology to the market, where she currently is chief technology officer. She holds a PhD in nanotechnology from the University of Vigo.